Sunzen Biotech Berhad (KLSE: SUNZEN)

Sunzen Biotech Berhad Revenue

In the fiscal year ending June 30, 2024, Sunzen Biotech Berhad had annual revenue of 95.13M MYR, down -3.05%. Sunzen Biotech Berhad had revenue of 20.61M in the quarter ending June 30, 2024, with 4.23% growth.

• Revenue: 95.13M
• Revenue Growth: +3.75%
• P/S Ratio: 2.52
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 242.62M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	95.13M	-3.00M	-3.05%
Dec 31, 2023	98.13M	1.04M	1.07%
Dec 31, 2022	97.09M	6.62M	7.31%
Dec 31, 2021	90.48M	8.25M	10.03%
Dec 31, 2020	82.23M	-158.35M	-65.82%